ANI PHARMACEUTICALS INC (ANIP)

US00182C1036 - Common Stock

64.95  -0.48 (-0.73%)

After market: 64.95 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ANI PHARMACEUTICALS INC

NASDAQ:ANIP (4/25/2024, 7:00:00 PM)

After market: 64.95 0 (0%)

64.95

-0.48 (-0.73%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap1.36B
Shares
PE13.76
Fwd PE14.25
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ANIP Daily chart

Company Profile

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The company is headquartered in Baudette, Minnesota and currently employs 600 full-time employees. The company went IPO on 2000-05-04. The firm is focused on developing and manufacturing niche oncology products (anti-cancer). The company has a commercial portfolio of over 111 products with a variety of indications and a portfolio of pipeline products. The firm owns the facility, which includes oral solid dose and liquid manufacturing and packaging, warehouse facilities, analytical, stability, and microbiological laboratory space, and employee office and mechanical space. The company also owns a manufacturing facility that includes oral solid dose manufacturing and packaging for pharmaceutical products. The firm has four pharmaceutical manufacturing facilities, of which two are located in Baudette, Minnesota, one is located in East Windsor, New Jersey and one is located in Oakville, Ontario.

Company Info

ANI PHARMACEUTICALS INC

210 Main Street West

Baudette MINNESOTA 56623

P: 12186343500

CEO: Nikhil Lalwani

Employees: 600

Website: https://www.anipharmaceuticals.com/

ANIP News

News Image8 days ago - ANI Pharmaceuticals, Inc.ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET

BAUDETTE, Minn., April 18, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company...

News Image15 days ago - Purcell & Lefkowitz LLPSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)

/PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) on behalf of the company's shareholders....

News Image17 days ago - ANI Pharmaceuticals, Inc.ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension

BAUDETTE, Minn., April 09, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Baclofen...

News Image22 days ago - ANI Pharmaceuticals, Inc.ANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month and Patients Living with Sarcoidosis

--ANI Pharmaceuticals is proud to support Sarcoidosis disease awareness--...

News Image23 days ago - ANI Pharmaceuticals, Inc.ANI Pharmaceuticals to Participate at the Piper Sandler Spring Biopharma Symposium

BAUDETTE, Minn., April 03, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani,...

News Image25 days ago - Market News VideoNoteworthy Monday Option Activity: ANIP, AMC, DOMO

ANIP Twits

Here you can normally see the latest stock twits on ANIP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example